The 'bioidentical/bioequivalent' hormone scam

Editorial

Alastair H MacLennan et al. Climacteric.2006 Feb.

No abstract available

Similar articles

Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
Patsner B.Patsner B.Food Drug Law J. 2008;63(2):459-91.Food Drug Law J. 2008.PMID:18561473No abstract available.
Comment on "Bioidentical hormone therapy: a review".
Marks M.Marks M.Menopause. 2004 Nov-Dec;11(6 Pt 1):641-2; author reply 642-3.Menopause. 2004.PMID:15545794No abstract available.
Bioidentical hormone therapy: a panacea that lacks supportive evidence.
Boothby LA, Doering PL.Boothby LA, et al.Curr Opin Obstet Gynecol. 2008 Aug;20(4):400-7. doi: 10.1097/GCO.0b013e3283081ae9.Curr Opin Obstet Gynecol. 2008.PMID:18660693
The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
Holtorf K.Holtorf K.Postgrad Med. 2009 Jan;121(1):73-85. doi: 10.3810/pgm.2009.01.1949.Postgrad Med. 2009.PMID:19179815Review.
Bioidentical hormones. Achieving the perfect fit.
Campbell S.Campbell S.Adv Nurse Pract. 2006 Feb;14(2):25-9; quiz 30.Adv Nurse Pract. 2006.PMID:16471303Review.No abstract available.

Defining bioidentical hormones for menopause-related symptoms.
Whelan AM, Jurgens TM, Trinacty M.Whelan AM, et al.Pharm Pract (Granada). 2011 Jan;9(1):16-22. doi: 10.4321/s1886-36552011000100003. Epub 2011 Mar 15.Pharm Pract (Granada). 2011.PMID:25132885Free PMC article.
Prescribing of FDA-approved and compounded hormone therapy differs by specialty.
Constantine GD, Archer DF, Graham S, Bernick BA, Mirkin S.Constantine GD, et al.Menopause. 2016 Oct;23(10):1075-82. doi: 10.1097/GME.0000000000000683.Menopause. 2016.PMID:27648594Free PMC article.